The blockage of IL-17 with the anti-IL-17A antibody has been shown to protect dairy cows from LPS-induced mastitis by suppressing the pro-inflammatory cytokine levels, myeloperoxidase activity, and neutrophil infiltration and NF-κB signaling pathway (175). The gene discussed is IL17A; the disease is mastitis.